Height benefit of GnRH agonists after age 8 in a Portuguese cohort of central precocious puberty
Sign Up to like & getrecommendations! Published in 2023 at "Clinical Endocrinology"
DOI: 10.1111/cen.14884
Abstract: Idiopathic central precocious puberty (iCPP) is common in paediatric endocrinology. Gonadotropin‐releasing hormone agonists (GnRHa) are safe, but the effect on final height and the ideal timing for treatment remains controversial. This study aims to assess… read more here.
Keywords: height benefit; precocious puberty; central precocious; endocrinology ... See more keywords